Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
Steven TisseverasingheMarwan TolbaFred SaadGwenaëlle GravisBoris BahoricTamim NiaziPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)